Lam Research LRCX Q1 2025 Earnings Transcript

Lam Research reported September-quarter revenue of $4.17 billion, up 8% sequentially, with gross margin of 48.2% and operating margin of 30.9% both above guidance. Free cash flow was $1.46 billion and the company returned $1.26 billion via buybacks and dividends, while maintaining a strong balance sheet and raising the dividend for a 10th straight year. Management guided December-quarter revenue to $4.3 billion plus or minus $300 million and said it expects WFE spending to grow in 2025, though China revenue is likely to decline as a share of mix.

Analysis

Lam’s setup is improving for reasons the market may still be underweighting: the company is shifting from a China-heavy, mature-node mix toward technology inflections that structurally raise etch/deposition content per wafer. That matters because the incremental dollar opportunity is no longer just cyclical WFE beta; it is share capture inside the fastest-growing pockets of the capex cycle, especially where Lam’s portfolio has gained credible attach points in selective etch, ALD, advanced packaging, and backside power.

The second-order implication is margin durability. A lower China mix is usually read as a gross-margin headwind, but that can be offset by a better product mix, higher CSBG attach, and more profitable installed-base monetization. If management is right that the company is still early in its operational footprint optimization, then the market may be underestimating how much of the China mix drag can be absorbed by a richer aftermarket and a higher factory-utilization regime as top-line growth resumes.

The key risk is not demand direction but timing: 2025 looks better, yet investor disappointment could come if NAND upgrades slip into 2026 or if China declines faster than the non-China growth engine can compensate in the first half. The more important contrarian point is that “China down” may actually be a quality signal, not a warning sign, because the lost mix appears concentrated in lower-value legacy spend while the replacement dollars are migrating to structurally better end-markets. That should keep Lam’s growth multiple supported unless WFE itself rolls over globally or export controls tighten unexpectedly.

The biggest hidden lever is installed-base productivity. If CSBG continues to accelerate, the company can compound returns even in a slower tool-shipment environment by monetizing the base through software-like services, upgrades, and chamber subscriptions. That creates a floor under earnings power and reduces the market’s dependence on a perfect replacement-cycle narrative.

Key Decisions for Investors

• Long LRCX outright on pullbacks over the next 2-6 weeks: risk/reward favors a re-rating if investors start pricing 2025 share gains in NAND, advanced packaging, and gate-all-around rather than only China mix headwinds.
• Pair trade: long LRCX / short a more China-exposed semi-cap equipment peer for 1-2 quarters. Thesis: Lam’s mix is rotating toward higher-content technology inflections while legacy China exposure compresses across the group unevenly.
• Buy LRCX Jan-2026 calls or call spreads on any post-earnings consolidation. The catalyst path is January WFE commentary plus evidence that NAND upgrade spending and CSBG remain resilient into 2025.
• Avoid chasing broad semiconductor equipment beta until January guidance: if WFE optimism proves real, Lam should outperform the basket; if not, its downside is cushioned by CSBG and capital returns.
• For hedged portfolios, pair long LRCX with short CXMT/China-legacy-node exposed supply-chain proxies only if export-control headlines intensify; that’s the cleanest way to express the “China down, quality up” theme.